Regenerative orthopedic market to hit $5.6B by 2030

Biologics

The worldwide orthopedic regenerative surgical product market is expected to reach $5.6 billion by 2030, according to Research and Markets.

Three things to know:

1. The compound annual growth rate for the orthopedic regenerative surgical product market is forecast to rise 3.9 percent between 2022 and 2030, according to an April 21 news release.

2. Key market growth drivers include the rising aging population, research and development in regenerative medicine and growing need for orthopedic care.

3. Market players named in the report include Zimmer Biomet, Stryker, Smith+Nephew and Allosource.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers